Successful Treatment of Nail Lichen Planus with a Lacquer Containing Urea, Keratinase, and a Retinoid Molecule: Report of 10 Cases
- PMID: 35496502
- PMCID: PMC8995628
- DOI: 10.1159/000523796
Successful Treatment of Nail Lichen Planus with a Lacquer Containing Urea, Keratinase, and a Retinoid Molecule: Report of 10 Cases
Abstract
Lichen planus is chronic inflammatory mucocutaneous disease. Involvement of nails (nail lichen planus: NLP) could be the only manifestation or it could be associated with the other typical skin and mucous localizations. Typical NLP alterations are linear nail bed dyschromia, longitudinal ridging, splitting, onycholysis, and subungual hyperkeratosis. Pterygium could be observed in advanced stages. Treatment of NLP is challenging. Limited clinical data have suggested that both oral and topical retinoids could be beneficial. Recently, a nail lacquer containing urea (20%), keratinase from Bacillus licheniformis, and hydroxipinacolone retinoate (U-KR lacquer) has been available. This product has shown good efficacy in the treatment of onychodystrophy characterized by onychogryphosis. We have evaluated, in a case series pilot study, the efficacy of this lacquer in subjects with moderate NLP. The product was applied once daily on the affected nails. Ten subjects (6 men and 4 women, mean age 38 years) after their written informed consent, with clinical NLP (2 subjects with histological confirmation) affecting foot or hand nails (mean number of nails involved: 4; range from 1 to 10), were treated for 12 consecutive weeks with U-KR, one application per day. The main endpoint was the evolution of a NLP severity score (NLPSS) evaluating 7 nail signs: grade of onycholysis, longitudinal ridging, splitting, grade of subungual hyperkeratosis, nail bed thickening, dyschromia, and nail pitting. For each item, a 4-grade score (from 0: no sign to 3: severe) was used (range of NLPSS from 0 to 21). At baseline, the NLPSS was 20.8 ± 3. After 12 weeks, the NLPSS showed a significant reduction to 4 ± 8.8, representing an 81% reduction in comparison with baseline value (p = 0.0001), with an absolute difference between means of -16.86 ± 2,586 (95% CI of the difference: from -22.49 to -11.22) The product was very well tolerated. This 10-case pilot study suggests that a nail lacquer with 3 components (urea, keratinase, and a retinoid molecule) could be useful in subjects with NLP. Future controlled trials are warranted to better define the therapeutic potential of this product in NLP treatment.
Keywords: Case report; Nail lichen planus; Topical retinoid; Urea.
Copyright © 2022 by S. Karger AG, Basel.
Conflict of interest statement
L.A. declared no conflicts of interest. M.M. is an employee of Difa Cooper, Cantabria Labs group.L.A. declared no conflicts of interest. M.M. is an employee of Difa Cooper, Cantabria Labs group.
Figures
Similar articles
-
Bullous Lichen Planus of the Nails: A Case Report and Review of the Literature.Case Rep Dermatol. 2023 Sep 4;15(1):133-141. doi: 10.1159/000533386. eCollection 2023 Jan-Dec. Case Rep Dermatol. 2023. PMID: 37933228 Free PMC article.
-
Clinical characteristics and management outcomes in isolated nail lichen planus: A retrospective case series.Indian J Dermatol Venereol Leprol. 2023 Oct 26:1-7. doi: 10.25259/IJDVL_449_2023. Online ahead of print. Indian J Dermatol Venereol Leprol. 2023. PMID: 38031689
-
Review of Nail Lichen Planus: Epidemiology, Pathogenesis, Diagnosis, and Treatment.Dermatol Clin. 2021 Apr;39(2):221-230. doi: 10.1016/j.det.2020.12.002. Epub 2021 Feb 10. Dermatol Clin. 2021. PMID: 33745635 Review.
-
Lichen planus limited to the nails in childhood: case report and literature review.Pediatr Dermatol. 1993 Mar;10(1):36-9. doi: 10.1111/j.1525-1470.1993.tb00010.x. Pediatr Dermatol. 1993. PMID: 8493165 Review.
-
Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer.J Eur Acad Dermatol Venereol. 2009 Jul;23(7):832-4. doi: 10.1111/j.1468-3083.2009.03209.x. Epub 2009 Apr 8. J Eur Acad Dermatol Venereol. 2009. PMID: 19470045 Clinical Trial.
Cited by
-
Lichen planus-the role of age and gender in clinical appearance and treatment : A narrative review.Wien Med Wochenschr. 2024 Nov 12. doi: 10.1007/s10354-024-01057-5. Online ahead of print. Wien Med Wochenschr. 2024. PMID: 39531121 Review. English.
-
Natural Treatment Options for Nail Disorders.Skin Appendage Disord. 2024 Apr;10(2):83-91. doi: 10.1159/000534629. Epub 2023 Dec 5. Skin Appendage Disord. 2024. PMID: 38572187 Free PMC article. Review.
-
Successful treatment of nail lichen planus with tofacitinib: a case report and review of the literature.Front Med (Lausanne). 2023 Nov 16;10:1301123. doi: 10.3389/fmed.2023.1301123. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034544 Free PMC article.
References
-
- Tosti A, Peluso AM, Fanti PA, Piraccini BM. Nail lichen planus: clinical and pathologic study of twenty-four patients. J Am Acad Dermatol. 1993;28((5 Pt 1)):724–30. - PubMed
-
- Zaias N. The nail in lichen planus. Arch Dermatol. 1970;101((3)):264–71. - PubMed
-
- Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med. 2012;366((8)):723–32. - PubMed
-
- Gupta MK, Lipner SR. Review of nail lichen planus: epidemiology, pathogenesis, diagnosis, and treatment. Dermatol Clin. 2021;39((2)):221–30. - PubMed
-
- Ujiie H, Shibaki A, Akiyama M, Shimizu H. Successful treatment of nail lichen planus with topical tacrolimus. Acta Derm Venereol. 2010;90((2)):218–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources